Edwards Lifesciences Corp Insider Trading Activity
Every SEC Form 4 insider transaction reported for Edwards Lifesciences Corp (EW), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are EW insiders buying or selling?
In the last 12 months, Edwards Lifesciences Corp insiders reported 0 open-market purchases ($0) and 41 sales ($27.7M) — net selling of $27.7M. Since January 2018, Trabud has recorded 526 Form 4 filings for EW: 2 buys ($218.1K) and 524 sells ($699.0M).
Source: SEC EDGAR Form 4
What stands out
- No Edwards Lifesciences Corp insider made an open-market purchase in the last 12 months; the 41 reported open-market sales totaled $27.7M.
Key Statistics (January 2018 – Oct 8, 2026)
Total Form 4 filings
526
SEC EDGAR
Insider filers
21
Insider buys (2)
$218.1K
Insider sells (524)
$699.0M
Insider sentiment
Net sellingNet insider flow of $698.8M in net selling since January 2018, and $27.7M in net selling over the last 12 months.
Recent EW insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Daniel J. Lippis | CVP, TAVR | Sale | 619 | $85.65 | $53.0K | SEC ↗ |
| Sep 11, 2026 | Daniel J. Lippis | CVP, TAVR | Sale | 619 | $87.51 | $54.2K | SEC ↗ |
| Aug 31, 2026 | Andrew M. Dahl | SVP, Corporate Controller | Sale | 544 | $91.06 | $49.5K | SEC ↗ |
| Aug 28, 2026 | Annette Bruls | CVP, EMEACLA | Sale | 2.6K | $89.98 | $237.9K | SEC ↗ |
| Aug 26, 2026 | Daveen Chopra | CVP, TMTT, Surgical & IHFM | Sale | 31.8K | $91.02 | $2.9M | SEC ↗ |
| Aug 26, 2026 | Wayne Markowitz | CVP, JAPAC | Sale | 1.2K | $91.47 | $113.4K | SEC ↗ |
| Aug 11, 2026 | Daniel J. Lippis | CVP, TAVR | Sale | 619 | $92.03 | $57.0K | SEC ↗ |
| Jul 30, 2026 | Wayne Markowitz | CVP, JAPAC | Sale | 146.31 | $86.03 | $12.6K | SEC ↗ |
| Jul 28, 2026 | Wayne Markowitz | CVP, JAPAC | Sale | 9.6K | $85.06 | $819.0K | SEC ↗ |
| Jul 27, 2026 | Bernard J Zovighian | CEO | Sale | 2.9K | $83.93 | $245.1K | SEC ↗ |
| Jul 10, 2026 | Daniel J. Lippis | CVP, TAVR | Sale | 619 | $91.70 | $56.8K | SEC ↗ |
| Jul 1, 2026 | Daniel J. Lippis | CVP, TAVR | Sale | 619 | $91.40 | $56.6K | SEC ↗ |
| Jun 18, 2026 | Bernard J Zovighian | CEO | Sale | 523 | $87.92 | $46.0K | SEC ↗ |
| May 29, 2026 | Andrew M. Dahl | SVP, Corporate Controller | Sale | 567.53 | $86.08 | $48.9K | SEC ↗ |
| May 27, 2026 | Donald E Bobo JR | CVP,Strategy/Corp Development | Sale | 23.1K | $86.42 | $2.0M | SEC ↗ |
| May 22, 2026 | Daveen Chopra | CVP, TMTT & Surgical | Sale | 1.5K | $84.60 | $126.9K | SEC ↗ |
| May 18, 2026 | Daniel J. Lippis | CVP, TAVR | Sale | 620 | $81.14 | $50.3K | SEC ↗ |
| May 18, 2026 | Donald E Bobo JR | CVP,Strategy/Corp Development | Sale | 18.0K | $81.96 | $1.5M | SEC ↗ |
| May 12, 2026 | Bernard J Zovighian | CEO | Sale | 36.4K | $77.93 | $2.8M | SEC ↗ |
| May 12, 2026 | Wayne Markowitz | CVP, JAPAC | Sale | 593 | $79.73 | $47.3K | SEC ↗ |
| May 4, 2026 | Daniel J. Lippis | CVP, TAVR | Sale | 2.0K | $83.49 | $170.2K | SEC ↗ |
| Apr 9, 2026 | Scott B. Ullem | CVP, Chief Financial Officer | Sale | 13.0K | $80.04 | $1.0M | SEC ↗ |
| Apr 7, 2026 | Daniel J. Lippis | CVP, TAVR | Sale | 1.0K | $80.98 | $82.5K | SEC ↗ |
| Apr 2, 2026 | Donald E Bobo JR | CVP,Strategy/Corp Development | Sale | 22.7K | $80.16 | $1.8M | SEC ↗ |
| Mar 11, 2026 | Scott B. Ullem | CVP, Chief Financial Officer | Sale | 13.0K | $84.92 | $1.1M | SEC ↗ |
Showing the 25 most recent of 526 Form 4 filings for Edwards Lifesciences Corp.
Most active EW insiders
- Donald E Bobo JR109 filings
- Michael A Mussallem77 filings
- Larry L Wood68 filings
- Huimin Wang55 filings
- Catherine M. Szyman53 filings
Ask anything about EW insider activity
Use Trabud's AI agent to query Edwards Lifesciences Corp's Form 4 history in plain English — "Show me EW CEO purchases this year" or compare it against any other ticker.
Open the AI agentEW insider trading FAQ
Are Edwards Lifesciences Corp insiders buying or selling?
In the last 12 months, Edwards Lifesciences Corp insiders reported 0 open-market purchases ($0) and 41 sales ($27.7M) — net selling of $27.7M. Since January 2018, Trabud has recorded 526 Form 4 filings for EW: 2 buys ($218.1K) and 524 sells ($699.0M). Over the full record that is net selling of $698.8M.
How many insiders trade EW stock?
21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Edwards Lifesciences Corp. The most recent filing was accepted on Oct 8, 2026.
Where does Trabud get EW insider trading data?
All EW insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.